Mirum Pharmaceuticals (MIRM) Preferred Stock Liabilities (2018 - 2019)

Mirum Pharmaceuticals' Preferred Stock Liabilities history runs 2 years deep, the most recent figure standing at $7.0 million for Q2 2019.

• In Q2 2019, Preferred Stock Liabilities changed N/A year-over-year to $7.0 million; the TTM figure through Jun 2019 stood at $7.0 million (changed N/A YoY), while the FY2018 annual figure was $59.8 million, changed N/A from the prior year.
• Preferred Stock Liabilities for Q2 2019 stood at $7.0 million, roughly flat from $7.0 million in the prior quarter.
• The five-year high for Preferred Stock Liabilities was $59.8 million in Q4 2018, with the low at $7.0 million in Q1 2019.